Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience

Effective treatments and vaccines against COVID-19 used in clinical practice have made a positive impact on controlling the spread of the pandemic, where they are available. Nevertheless, even if fully vaccinated, immunocompromised patients still remain at high risk of adverse outcomes. This has dri...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinosoglou, Karolina, Rigopoulos, Emmanouil-Angelos, Kaiafa, Georgia, Daios, Stylianos, Karlafti, Eleni, Ztriva, Eleftheria, Polychronopoulos, Georgios, Gogos, Charalambos, Savopoulos, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866621/
https://www.ncbi.nlm.nih.gov/pubmed/36680160
http://dx.doi.org/10.3390/v15010118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866621/
https://www.ncbi.nlm.nih.gov/pubmed/36680160
http://dx.doi.org/10.3390/v15010118

Ejemplares similares